Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 7 (July)

1. Aurora kinase A as a rational target for therapy in glioblastoma.
   J Neurosurg Pediatr, 6(1): 98-105. [Abstract] [Full-text]
2. Establishment of a human glioblastoma stemlike brainstem rodent tumor model.
   J Neurosurg Pediatr, 6(1): 92-7. [Abstract] [Full-text]
3. Cranial magnetic resonance imaging findings of leptomeningeal contrast enhancement after pediatric posterior fossa tumor resection and its significance.
   J Neurosurg Pediatr, 6(1): 87-91. [Abstract] [Full-text]
4. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.
   Oncogene, 29(26): 3793-802. [Abstract] [Full-text]
5. Notch signaling is not essential in sonic hedgehog-activated medulloblastoma.
   Oncogene, 29(26): 3865-72. [Abstract] [Full-text]
6. Cushing's lost cases of "radium bomb" brachytherapy for gliomas.
   J Neurosurg, 113(1): 141-8. [Abstract] [Full-text]
7. The PEA-15 protein regulates autophagy via activation of JNK.
   J Biol Chem, 285(28): 21644-54. [Abstract] [Full-text]
8. Potential therapeutic implications of cancer stem cells in glioblastoma.
   Biochem Pharmacol, 80(5): 654-65. [Abstract] [Full-text]
9. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
   Int J Cancer, 127(5): 1038-51. [Abstract] [Full-text]
10. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.
    Int J Radiat Oncol Biol Phys, 77(4): 1134-9. [Abstract] [Full-text]
11. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
    Int J Radiat Oncol Biol Phys, 77(4): 1009-16. [Abstract] [Full-text]
12. Optimal treatment for intracranial germinoma: can we lower radiation dose without chemotherapy?
    Int J Radiat Oncol Biol Phys, 77(4): 980-7. [Abstract] [Full-text]
13. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Int J Radiat Oncol Biol Phys, 77(4): 974-9. [Abstract] [Full-text]
14. Investigating verbal and visual auditory learning after conformal radiation therapy for childhood ependymoma.
    Int J Radiat Oncol Biol Phys, 77(4): 1002-8. [Abstract] [Full-text]
15. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 77(4): 996-1001. [Abstract] [Full-text]
16. CD147 expression in pituitary adenomas and its significance for clinical outcome.
    Hum Pathol, 41(8): 1165-71. [Abstract] [Full-text]
17. Results of a multi-institutional benchmark test for cranial CT/MR image registration.
    Int J Radiat Oncol Biol Phys, 77(5): 1584-9. [Abstract] [Full-text]
18. Radiosurgery for brain metastases from unknown primary cancers.
    Int J Radiat Oncol Biol Phys, 77(5): 1457-62. [Abstract] [Full-text]
19. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
    Int J Radiat Oncol Biol Phys, 77(5): 1449-56. [Abstract] [Full-text]
20. Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging.
    J Vis Exp. [Abstract] [Full-text]
21. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    J Natl Cancer Inst, 102(14): 1052-68. [Abstract] [Full-text]
22. Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.
    Clin Pharmacol Ther, 88(2): 204-13. [Abstract] [Full-text]
23. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
    Pediatr Blood Cancer, 55(3): 577-9. [Abstract] [Full-text]
24. Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy.
    Pediatr Blood Cancer, 55(3): 570-2. [Abstract] [Full-text]
25. Body weight, social competence, and cognitive functioning in survivors of childhood brain tumors.
    Pediatr Blood Cancer, 55(3): 532-9. [Abstract] [Full-text]
26. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors.
    Pediatr Blood Cancer, 55(3): 525-31. [Abstract] [Full-text]
27. Measuring performance status in pediatric patients with brain tumors--experience of the HIT-GBM-C protocol.
    Pediatr Blood Cancer, 55(3): 520-4. [Abstract] [Full-text]
28. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
    Pediatr Blood Cancer, 55(3): 471-7. [Abstract] [Full-text]
29. Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.
    Am J Surg Pathol, 34(8): 1199-204. [Abstract] [Full-text]
30. Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients.
    Eur J Endocrinol, 163(2): 193-200. [Abstract] [Full-text]
31. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.
    Jpn J Clin Oncol, 40(8): 726-31. [Abstract] [Full-text]
32. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Jpn J Clin Oncol, 40(8): 788-94. [Abstract] [Full-text]
33. Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells.
    Int J Cancer, 127(6): 1271-82. [Abstract] [Full-text]
34. Alpha3* and alpha 7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells.
    Neurochem Int, 57(3): 269-77. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.